Alternative Securities Markets Group Welcomes BioSculpture Technology, Inc

Mr. Steven J. Muehler, Founder and Chief Executive Officer of the Alternative Securities Markets Group, welcomes BioSculpture Technology, Inc. to the Alternative Securities Market’s Main Market.
 
BEVERLY HILLS, Calif. - Aug. 25, 2014 - PRLog -- Monday, August 25th, 2014 (Beverly Hills, California) – The Alternative Securities Markets Group, the operator of a global private, transparent equity and debt marketplace, today announced that BioSculpture Technology, Inc. is in the final stages of qualification of its Regulation A Securities Registration Statement with the United States Securities & Exchange Commission and is expected to offer its Common Stock Shares to the Investment Public in September of 2014. BioSculpture Technology, Inc. is listed on the Main Market of the Alternative Securities Market, and is also listed on the “Alternative Securities Markets Group’s Medical Device and Pharmaceuticals Market”.

The Alternative Securities Markets Group’s Medical Device and Pharmaceuticals Market was formed to, (1) operate as both an independent Primary and Secondary Segment of the Alternative Securities Market for the Initial Public Offering of Securities to the investing public and for the establishment of a secondary trading market for the resale of securities for companies listed on the Alternative Securities Markets Group’s Medical Device and Pharmaceuticals Market, and (2) to act as a Private Equity Capital Partner to early and growth stage Medical Device and Pharmaceuticals Industry companies. The Alternative Securities Markets Group’s Medical Device and Pharmaceuticals Market, LLC will invest into multiple early and growth stage Medical Device and Pharmaceuticals Companies in the United States, Canada and Internationally.

“We are pleased to welcome Dr. Cucin and his company, BioSculpture Technology, Inc. to the Alternative Securities Market”, said Mr. Steven J. Muehler, Founder and Chief Executive Officer of the Alternative Securities Markets Group. “The Direct Initial Public Offering and Listing on the Alternative Securities Market will help BioSculpture Technologies, Inc. increase its visibility with both U.S. Investors and International Investors by providing them the most transparent investing and convenient 24/7 access to news and financial information about the Company, and the markets as a whole”.

All SEC Filings can be found on each Company Page at www.AlternativeSecuritiesMarket.com and https://www.sec.gov/cgi-bin/browse-edgar?company=Biosculpture+technology&owner=exclude&action=getcompany

Additional Information about BioSculpture Technology, Inc., and Dr. Cucin can be found at: http://www.biosculpturetechnology.com/

Additional Information about the Alternative Securities Market can be found at: http://www.AlternativeSecuritiesMarket.com

Additional Information about Mr. Steven J. Muehler can be found at: http://www.SteveMuehler.com

The Alternative Securities Markets Group can be followed on Twitter at: https://twitter.com/AltSecMarket

This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

All trademarks and service marks are the property of the respective parties.

NEWS SOURCE:  Alternative Securities Markets Group

Contact
Alternative Securities Markets Group
***@asmmarketsgroup.com
End
Alternative Securities Markets Group News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share